Requirement for prolonged action in the cytosol for optimal protein synthesis inhibition by diphtheria toxin

J Biol Chem. 2000 Feb 11;275(6):4363-8. doi: 10.1074/jbc.275.6.4363.

Abstract

Diphtheria toxin A-fragment enters the cytosol of target cells, where it inhibits protein synthesis by catalyzing ADP-ribosylation of elongation factor 2 (EF-2). We have here analyzed toxin-induced protein synthesis inhibition in single cells by autoradiography and compared it with inhibition of protein synthesis in the whole cell culture. The data show that half-maximal protein synthesis inhibition in the whole cell population after a short incubation time is achieved by partially inhibiting protein synthesis in basically all the cells, while half-maximal protein synthesis inhibition after a long incubation time is due to a complete protein synthesis block in about half the cells in the population. We have also compared stable and unstable A-fragment mutants with respect to the kinetics of cell intoxication. While the toxicity of the stable mutants increased with time, the unstable mutants showed a similar toxicity at early and late time points. When studying the kinetics of cell intoxication by toxins with short cytosolic half-life, we could not detect any recovery of protein synthesis at late time points when all the mutant A-fragments should be degraded. This indicates that the ADP-ribosylation of EF-2 cannot be reversed by an endogenous activity in the cells. The data indicate that entry of toxin into a cell is not associated with an immediate block in protein synthesis, and that prolonged action of single A-fragment molecules in the cytosol is sufficient to obtain complete protein synthesis inhibition at low toxin concentrations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chlorocebus aethiops
  • Cytosol / metabolism*
  • Diphtheria Toxin / genetics
  • Diphtheria Toxin / pharmacology*
  • Hydrogen-Ion Concentration
  • Kinetics
  • Mutation
  • Peptide Elongation Factor 2 / metabolism
  • Peptide Fragments / genetics
  • Peptide Fragments / pharmacology*
  • Protein Biosynthesis*
  • Protein Synthesis Inhibitors / pharmacology*
  • Vero Cells

Substances

  • Diphtheria Toxin
  • Peptide Elongation Factor 2
  • Peptide Fragments
  • Protein Synthesis Inhibitors
  • diphtheria toxin fragment A